Telix Pharmaceuticals Ltd Stock Price, News & Catalysts

Stock performance

Why the stock is moving

As of Sep 17, 2026, TLX closed up 5.71% at $12.51. No new same-company headline was identified in the current news window.

Company overview

Future catalysts

Recent news

1. 01
   2026-09-14 10:30 EST

   FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

2. 02
   2026-09-09 10:30 EST

   Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

3. 03
   2026-09-01 22:18 EST

   Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

4. 04
   2026-08-31 22:21 EST

   Telix Appoints David Gill as Chair

5. 05
   2026-08-20 00:32 EST

   Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions